Frequently Asked Questions
The market is segmented based on , By Treatment (Topical Therapy, Phototherapy, Systemic Agents, Biologic Therapies, Others), Route of Administration (Oral, Injectable), End Users (Hospitals, homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Industry Trends and Forecast to 2029
.
The Global Plaque Psoriasis Market size was valued at USD 1.00 USD Billion in 2022.
The Global Plaque Psoriasis Market is projected to grow at a CAGR of 6.5% during the forecast period of 2023 to 2030.
The major players operating in the market include Pfizer , GlaxoSmithKline plc, Novartis AG, Mylan N.V, Teva Pharmaceutical Industries Ltd, Sanofi, Boehringer Ingelheim International GmbH, AstraZeneca, Johnson & Johnson Private Limited, Bayer AG, Merck & Co., F. Hoffmann-La Roche Ltd, Bristol,Myers Squibb Company, Cadila Pharmaceuticals, Eli Lilly and Company, LEO Pharma A/S, Cipla , Aurobindo Pharma, Lupin, Sumitomo Corporation.
The market report covers data from the U.S., Canada ,Mexico, Germany, Italy, France, Spain, UK, Switzerland, Russia, Turkey, Belgium, Netherlands and Rest of Europe, China, India, Japan, South Korea, Australia, Singapore, Indonesia, Thailand, Malaysia, Philippines and Rest of Asia-Pacific, Brazil, Argentina and Rest of South America., UAE, Saudi Arabia, Egypt, South Africa, Israel, Rest of Middle East and Africa.
